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Abstract 
Sclerosing mesenteritis falls within a spectrum of primary idiopathic inflammatory and fibrot-
ic processes that affect the mesentery. The exact etiology has not been determined, although 
the following associations have been noted: abdominal surgery, trauma, autoimmunity, 
paraneoplastic syndrome, ischemia and infection. Progression of sclerosing mesentritis can 
lead to bowel obstruction, a rare complication of this uncommon condition. We report a case 
of a 66-year-old female with abdominal pain who was noted to have a small bowel obstruc-
tion requiring laparotomy and a partial small bowel resection. The pathology of the resected 
tissue was consistent with sclerosing mesenteritis, a rare cause of a small bowel obstruction. 
Sclerosing mesenteritis has variable rates of progression, and there is no consensus regard-
ing the optimal treatment. Physicians should consider sclerosing mesenteritis in the differen-
tial diagnosis of a small bowel obstruction. © 2016 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Sclerosing mesenteritis is a rare idiopathic inflammatory and fibrotic disorder primarily 
affecting the small bowel mesentery. The spectrum of this disease has included terms such 
as mesenteric lipodystrophy, mesenteric panniculitis, mesenteric sclerosis and retractile 
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mesenteritis [1, 2]. The mesenteric vessels and gastrointestinal lumen integrity is compro-
mised by mass effect, which leads to the clinical findings. The most common systemic mani-
festations include abdominal pain, nausea, vomiting, diarrhea, weight loss and rarely ascites 
and small bowel obstruction. The physical examination is significant for abdominal tender-
ness and an abdominal mass often palpated in the left upper quadrant or epigastrium in up 
to 50% of patients. The mass is often deep and poorly defined. Examination findings are 
often nonspecific making imaging essential. The imaging modality of choice is a dual-phase 
abdominal computed tomography (CT). The most common finding on CT is a soft tissue mass 
within the small bowel mesentery. Two signs seen on CT, i.e. ‘fat ring’ and ‘tumor pseudo-
capsule’, are considered somewhat specific for mesenteric panniculitis. Immunohistochemi-
cal staining can also be helpful with IgG4 showing the most promise. Our case illustrates a 
rare case of small bowel obstruction due to sclerosing mesenteritis with immunohistochem-
ical staining for IgG4, supporting the diagnosis of this rare cause of small bowel obstruction.  
Case Report 
A 66-year-old Caucasian female presented with an acute worsening of a several-year 
history of intermittent periumbilical abdominal pain, nausea, vomiting and diarrhea. She had 
an extensive workup in the past including multiple CT scans, upper endoscopies and colon-
oscopies without any significant findings. Her medical history is significant for mild reflux 
and chronic obstructive pulmonary disease. Her medications included tiotropium, 
esomeprazole, and as needed doxylamine succinate for sleep. On her current presentation, 
she reported diffuse abdominal pain and distention with an absence of flatus for 1–2 days. 
On examination, her abdomen was distended, tympanic to percussion and had slightly in-
creased bowel sounds. A complete blood count was obtained with hemoglobin of 14.3 g/dl 
(normal level 12.0–16.0 g/dl), a white blood cell count of 9.2 k/μl (nl 4.5–11.0 k/μl) and 
platelet count at 385 k/μl (normal level 150–440 k/μl). An erythrocyte sedimentation rate 
and C-reactive protein were not collected. She underwent a CT scan showing moderate asci-
tes and dilated loops of small bowel consistent with a small bowel obstruction. The following 
malignancy markers were all within the normal range: carcinoma antigen 125 was 6, carbo-
hydrate antigen 19–9 was 8 and carcinoembryonic antigen was 0.7. A nasogastric tube was 
placed for decompression, and she was made NPO (nothing by mouth). General surgery was 
consulted, and the decision was made to operate. She underwent a laparotomy with a distal 
small bowel resection with a primary anastomosis. On gross inspection, the distal ileum had 
a thickened bowel wall and a narrowed lumen. Inflammatory cells and fibroblasts were iden-
tified on histologic review. Special immunohistologic staining was positive for IgG4. The 
histologic specimens are shown in figure 1a and b. Postoperatively, the patient recovered 
well and was discharged home. She underwent a follow-up MRI enterography of the small 
bowel with no remaining disease evident. She remains asymptomatic other than an occa-
sional loose stool 1 year out from her surgery on no form of maintenance medication. She 
has not had a recurrence of her abdominal pain, and she has maintained a stable weight. 
Discussion 
Sclerosing mesenteritis is a rare inflammatory and fibrosing disorder of unknown etiol-
ogy that was first described by Jura [3] in 1924. This disorder affects primarily adipose tis-
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sue of the small bowel mesentery [4] in western patients, although in Japanese patients, the 
disease often involves the large bowel mesentery [5]. The spectrum includes varying degrees 
of inflammation of the mesenteric fat, which leads to wide and variable histological features. 
Several possible causative factors have been noted to include abdominal surgery and trauma 
[6], autoimmune processes, ischemic injury, and infection, although the exact etiology is 
unknown [2].  
Sclerosing mesenteritis often presents with nonspecific symptoms related to the mesen-
teric mass encasing the bowel, blood vessels and lymphatics, leading to abdominal pain, 
bowel obstruction, ischemia and possibly chylous ascites making the diagnosis difficult [2]. 
In the study by Akram et al. [1], looking at 92 cases of sclerosing mesenteritis, the most fre-
quent presenting symptoms were abdominal pain (70%), bloating and distention (26%), 
diarrhea (25%), and weight loss (23%). Sclerosing mesenteritis appears to affect men twice 
as much as women and is usually diagnosed in the 6th or 7th decade of life [1]. Blood tests 
are usually normal as was the case with our patient. Occasionally, elevation of the erythro-
cyte sedimentation rate, neutrophilia, or anemia can be seen [7]. Colonoscopy is usually 
normal since the disease is extrinsic to the bowel [7], and since the disease primary involves 
the small bowel mesentery. There has been an association between sclerosing mesenteritis 
and fibrosclerotic disorders involving other organs, suggesting these conditions represent a 
spectrum of disorders leading to the inflammation and fibrosis of multiple organs [1]. 
This patient’s gross pathology and histologic findings are consistent with the diagnosis 
of sclerosing mesenteritis. On review of the gross specimen, diffuse mesenteric thickening 
was seen. Fibrosis and chronic inflammation were seen microscopically (fig. 1a). Special 
staining for our patient was positive for IgG4-positive plasma cells (fig. 1b), which is con-
sistent with and supports the diagnosis of sclerosing mesenteritis. Our patient’s serum IgG4 
level was also elevated at 103 mg/dl (normal level 4–86 mg/dl). Some series have shown 
that a subset of patients with sclerosing mesenteritis have lesions that stain abundantly for 
IgG4 [1, 8], and some have proposed that sclerosing mesenteritis could belong to the class of 
IgG4-related sclerosing disorders [8]. In the study by Akram et al. [1], 33% of the cases had 
abundant tissue infiltration of IgG4-positive plasma cells. Immunohistochemical staining has 
shown abundant tissue infiltration of IgG4-positive plasma cells, as well as CD3-positive T 
cells and CD19/CD20-positive B cells in some cases [1]. 
An abdominal mass is the most common finding on CT scan and is often misdiagnosed as 
a neoplasm. In the study by Kipfer et al. [9], a mass in the left upper quadrant was the most 
common, and usually the only, physical examination finding. Kipfer et al. [9] described three 
patterns of mesenteric involvement: type I was the most common and had diffuse mesenter-
ic thickening; type II involved a discrete mass, and type III is the least common with multiple 
discrete masses. Sclerosing mesenteritis is generally considered very rare, although a retro-
spective study of CT images performed for various reasons suggested a prevalence of 0.6% 
[10].  
The most common finding on CT is a soft tissue mass within the small bowel mesentery. 
Two signs seen on CT ‘fat ring’ and ‘tumoral pseudocapsule’ are considered somewhat spe-
cific for mesenteric panniculitis [5]. The ‘fat ring’ sign is due to preservation of the fat near-
est the mesenteric vessels [11], while the ‘tumoral pseudocapsule’ represents separation of 
the uninvolved mesentery from the inflamed fat by a band of tissue [12]. Some have report-
ed an increased association with malignancies including lymphomas, urogenital or gastroin-
tenstinal adenocarcinomas [10], although this is unclear [2]. In the study by Daskalogiannaki 
et al. [10], 69% of patients with mesenteric panniculitis diagnosed by CT scan had a coexist-
ing malignancy.  
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The differential diagnosis includes other diseases that can affect the mesentery includ-
ing lymphomas, desmoid tumors, carcinoid tumors, carcinomatosis, amyloidosis, and mesen-
teric fibromatosis. Definitive diagnosis requires a surgical excision, although the diagnosis is 
often made based upon the findings on CT scan. It is believed to have a benign, stable or 
slowly progressive course in the majority of cases, although there are cases of rapidly fatal 
disease [13]. There is no consensus regarding the optimal treatment, and numerous agents 
such as steroids, colchicine, azathioprine, tamoxifen and others have been used with varying 
success [7]. Surgery is usually indicated for a small bowel obstruction, as was the case in our 
patient. Many of the treatment regimens are anecdotal due to the rarity of the disease, alt-
hough one suggested regimen for patients with nonobstructive symptoms is a combination 
of tamoxifen with a prednisone taper over 3 months [5]. 
Sclerosing mesenteritis is a rare cause of small bowel obstruction with varying degrees 
of progression. Due to the nonspecific symptoms, diagnosis is often challenging. CT scans are 
often suggestive but not necessarily diagnostic. Various treatment regimens have been used, 
although often anecdotal. Clinicians must maintain a high level of suspicion for the disease, 
and this must be included in the differential diagnosis of a case of small bowel obstruction.  
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Fig. 1. a Hematoxylin and eosin stain illustrating fibrosis and chronic inflammation. ×40. b Tissue staining 
positive for IgG4 plasma cells. ×100. 
 
